BPC-157, TB-500 (Blend)

Key points

• The blend combines BPC-157 and TB-500, two peptides studied for tissue repair.
• Both are researched mostly in animals, with very limited human evidence.
• Neither is licensed in the UK, and combining them does not change that.
• Both are on the WADA Prohibited List.

Quick facts

What it is

Blend of BPC-157 and TB-500

Marketed for

Tissue repair and recovery

UK status

Not a licensed medicine; sold for research use

In sport

Both components prohibited

How it works

Both peptides are studied for supporting the healing of tissue such as tendon and muscle, through different pathways. Each is covered in its own entry, where the animal based evidence and its limits are set out.

What the evidence shows

There is no evidence for this blend as a specific product. The components have mostly animal evidence individually, and there are no human trials of the combination.

What it does not settle

• There are no human trials of this blend.
• The exact contents of a given vial are uncertain.
• Long term safety of the combination is unknown.

Side effects

Less common but serious

• The risks are those of the individual components, with the added uncertainty of what a blended product contains.
• Because there is no licensed product, the dose, purity and contents of material bought online cannot be verified.

Report any suspected side effect through the MHRA Yellow Card scheme.

UK legal status and access

This blend has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is sold online for research use.

Common questions